Coalition for Epidemic Preparedness Innovations (CEPI) Deal History & Licensing Activity
Coalition for Epidemic Preparedness Innovations (CEPI) is a life sciences. Over the past three years, Coalition for Epidemic Preparedness Innovations (CEPI) has been involved in 1 licensing and acquisition transaction, with a primary focus on mRNA (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
mRNA
Focus Area
Infectious Disease
Coalition for Epidemic Preparedness Innovations (CEPI) Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Coalition for Epidemic Preparedness Innovations (CEPI) in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| mRNA-1018 | Moderna | mRNA | Phase 3 | collaboration | Dec 2025 |
Coalition for Epidemic Preparedness Innovations (CEPI) Pipeline Focus
Therapeutic areas and modalities where Coalition for Epidemic Preparedness Innovations (CEPI) is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Coalition for Epidemic Preparedness Innovations (CEPI)'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
mRNA Benchmarks
Upfront, milestone, and royalty benchmarks for mrna deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Coalition for Epidemic Preparedness Innovations (CEPI) Licensing & Deal Activity
Coalition for Epidemic Preparedness Innovations (CEPI) is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Coalition for Epidemic Preparedness Innovations (CEPI) ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Coalition for Epidemic Preparedness Innovations (CEPI) include Infectious Disease (2 deals and trials). In terms of modality, Coalition for Epidemic Preparedness Innovations (CEPI) has shown particular interest in mrna.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Coalition for Epidemic Preparedness Innovations (CEPI) and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Coalition for Epidemic Preparedness Innovations (CEPI)'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.